Presentations made painless

Company > AngioDynamics Inc: Business Model, SWOT Analysis, and Competitors 2023

AngioDynamics Inc: Business Model, SWOT Analysis, and Competitors 2023

Published: Mar 24, 2023

Inside This Article


    AngioDynamics Inc is a prominent medical technology company that specializes in the development and manufacturing of innovative medical devices for minimally invasive surgeries. Their business model revolves around providing cutting-edge solutions for physicians and healthcare professionals to improve patient outcomes. This blog article will delve into AngioDynamics' business model, conducting a comprehensive SWOT analysis to evaluate their strengths, weaknesses, opportunities, and threats. Additionally, we will analyze their key competitors in the market and discuss the company's strategies to stay ahead in the dynamic medical technology industry by 2023.

    What You Will Learn:

    • Who owns AngioDynamics Inc and how the ownership structure impacts the company's decision-making and operations.
    • The mission statement of AngioDynamics Inc and how it guides the company's strategic goals and actions.
    • How AngioDynamics Inc generates revenue and the key sources of its income, including an overview of its business model and revenue streams.
    • An explanation of the AngioDynamics Inc Business Model Canvas, breaking down the key components and illustrating how they work together.
    • An overview of the main competitors of AngioDynamics Inc, providing insights into the competitive landscape of the industry.
    • A comprehensive SWOT analysis of AngioDynamics Inc, examining its strengths, weaknesses, opportunities, and threats, which can help in understanding the company's current position and future prospects.

    Who owns AngioDynamics Inc?

    Major shareholders of AngioDynamics Inc

    AngioDynamics Inc, a leading medical technology company, has a diverse group of major shareholders. These shareholders play a crucial role in shaping the company's direction and decision-making processes.

    Institutional investors

    Institutional investors are significant stakeholders in AngioDynamics Inc. These investors typically include mutual funds, pension funds, insurance companies, and other large financial institutions. Their participation in the company highlights the confidence they have in its growth potential and the value it offers to investors.

    Institutional investors provide stability and long-term support to AngioDynamics Inc. Their large-scale investments often indicate a belief in the company's ability to generate sustainable returns over time. Furthermore, the involvement of institutional investors can attract the interest of other potential investors, contributing to the overall growth and success of AngioDynamics Inc.

    Insider ownership

    Insider ownership refers to the shares of a company held by its executives, directors, and other individuals closely affiliated with the organization. In the case of AngioDynamics Inc, insiders have a significant stake in the company. This level of ownership is an encouraging sign for investors, as it aligns the interests of the management team with those of the shareholders.

    Insider ownership ensures that the executives and directors have a vested interest in the company's success. This alignment of interests can result in better decision-making, increased transparency, and a focus on long-term value creation. Investors often view high insider ownership positively, as it signifies the confidence and commitment of those who know the business intimately.

    Public shareholders

    Public shareholders include individual retail investors who own shares of AngioDynamics Inc. These investors are not affiliated with the company or its management. Their ownership is typically in the form of common shares purchased through stock exchanges.

    Public shareholders can be an essential source of capital for AngioDynamics Inc. Their investments provide the necessary liquidity for the company's shares and contribute to its overall market value. Public shareholders also have the opportunity to participate in the company's growth and benefit from any increase in its stock price.


    The ownership of AngioDynamics Inc is a combination of institutional investors, insiders, and public shareholders. This diverse group of stakeholders contributes to the stability, growth, and success of the company. Their collective ownership reflects the confidence and belief in AngioDynamics Inc's potential to deliver value to its shareholders.

    What is the mission statement of AngioDynamics Inc?

    The Mission Statement of AngioDynamics Inc: Advancing Patient Care through Innovation

    AngioDynamics Inc, a leading medical technology company, is driven by a clear and concise mission statement that guides its operations and strategic decisions. The mission statement of AngioDynamics Inc is centered around advancing patient care through innovation.

    At its core, AngioDynamics Inc is committed to improving the lives of patients by developing and delivering cutting-edge medical devices and therapies. Their mission statement reflects their dedication to pushing the boundaries of medical technology to provide healthcare professionals with innovative tools to enhance patient outcomes.

    By placing a strong emphasis on innovation, AngioDynamics Inc aims to revolutionize the field of medical technology. They constantly seek new solutions, technologies, and approaches that can address unmet medical needs and improve the standard of care provided to patients worldwide.

    This mission statement aligns with AngioDynamics Inc's commitment to being at the forefront of healthcare advancements. They strive to translate scientific discoveries into practical applications that can be readily adopted by healthcare professionals. Through their innovative products and therapies, AngioDynamics Inc aims to make a lasting impact on patient care.

    Furthermore, AngioDynamics Inc acknowledges the importance of collaboration and partnerships in achieving their mission. They actively seek to collaborate with healthcare providers, research institutions, and other industry stakeholders to develop novel solutions and bring them to market. By fostering a collaborative environment, AngioDynamics Inc can leverage collective expertise and resources to accelerate innovation and ultimately improve patient outcomes.

    In summary, the mission statement of AngioDynamics Inc encapsulates their commitment to advancing patient care through innovation. By constantly pushing the boundaries of medical technology, collaborating with industry partners, and delivering innovative solutions, AngioDynamics Inc strives to make a positive impact on the lives of patients worldwide.

    How does AngioDynamics Inc make money?

    Medical Devices

    One of the primary ways AngioDynamics Inc generates revenue is through the sale of medical devices. The company designs, manufactures, and sells a wide range of minimally invasive medical devices used in the treatment of vascular diseases and conditions. These devices include catheters, needles, guidewires, and other innovative tools that are essential for various medical procedures.

    AngioDynamics' medical devices are used by healthcare professionals in hospitals, clinics, and ambulatory surgical centers worldwide. The company focuses on developing cutting-edge technologies that improve patient outcomes and enhance the efficiency of medical procedures. By offering a diverse portfolio of high-quality devices, AngioDynamics is able to capture market share and generate substantial revenue in the medical device industry.

    Consumable Products

    In addition to medical devices, AngioDynamics Inc also generates revenue through the sale of consumable products. These products are used in conjunction with the medical devices and are often disposable or single-use items. Examples of consumable products offered by the company include infusion sets, drainage systems, thrombolytic agents, and embolic materials.

    Consumable products play a critical role in patient care as they are frequently used in various treatments and procedures. AngioDynamics ensures a steady stream of revenue by providing a wide range of consumables that are compatible with their medical devices. This strategy not only helps in establishing long-term relationships with customers but also allows the company to benefit from recurring purchases of consumables.

    Services and Support

    Apart from the sale of medical devices and consumable products, AngioDynamics Inc also generates revenue through its services and support offerings. The company provides comprehensive support to healthcare professionals by offering training, technical assistance, and maintenance services for their products.

    AngioDynamics' team of experts ensures that healthcare providers are well-equipped to use their medical devices effectively and safely. They offer training programs and workshops to educate medical professionals on the proper use and handling of their products. Additionally, the company provides ongoing technical support, troubleshooting assistance, and timely maintenance services to ensure optimal performance and longevity of their devices.

    By offering a range of services and support options, AngioDynamics not only strengthens its relationship with customers but also generates additional revenue streams. These services are crucial in building customer loyalty and differentiating the company from competitors in the medical device industry.

    AngioDynamics Inc Business Model Canvas Explained


    The Business Model Canvas is a strategic management tool that provides a visual representation of a company's key elements and how they work together to create value for customers and generate revenue. In this blog post, we will explore AngioDynamics Inc's Business Model Canvas to gain a deeper understanding of how this medical device company operates in the healthcare industry.

    Key Partnerships

    AngioDynamics Inc forms strategic partnerships with various stakeholders to enhance its product offerings and expand its market reach. The company collaborates with hospitals, healthcare providers, and physicians to understand their needs and develop solutions that address specific medical conditions. These partnerships enable AngioDynamics Inc to access a wider customer base and gain valuable insights into the industry trends.

    Additionally, the company partners with suppliers to ensure a consistent supply of high-quality medical devices. By maintaining strong relationships with suppliers, AngioDynamics Inc can reduce production costs and improve the overall quality of its products.

    Key Activities

    The key activities of AngioDynamics Inc revolve around the research, development, and manufacturing of innovative medical devices. The company invests heavily in research and development to create cutting-edge technologies that address critical healthcare challenges. This focus on innovation allows AngioDynamics Inc to differentiate itself in the market and stay ahead of competitors.

    Moreover, the company actively engages in marketing and sales activities to promote its products to healthcare professionals and institutions. By participating in medical conferences, trade shows, and educational events, AngioDynamics Inc can showcase its products and build relationships with potential customers.

    Key Resources

    AngioDynamics Inc relies on various key resources to deliver its products and services effectively. The company's research and development department plays a crucial role in developing new medical devices and improving existing ones. Skilled scientists, engineers, and healthcare professionals form the backbone of this department, ensuring that AngioDynamics Inc remains at the forefront of medical device innovation.

    Furthermore, the company's manufacturing facilities are essential resources for producing high-quality medical devices. These facilities adhere to strict quality control standards to ensure that the devices meet regulatory requirements and are safe for patient use.

    Value Proposition

    AngioDynamics Inc's value proposition lies in its ability to provide innovative and effective medical devices that improve patient outcomes. By focusing on research and development, the company develops products that address unmet medical needs and offer unique benefits to healthcare providers and patients alike. These devices enable physicians to perform minimally invasive procedures, reduce patient recovery time, and enhance overall treatment efficacy.

    Customer Segments

    AngioDynamics Inc primarily targets healthcare institutions, such as hospitals, clinics, and ambulatory surgical centers, as its customer segments. These institutions rely on medical devices to deliver high-quality care to their patients. The company also caters to healthcare professionals, including physicians and surgeons, who utilize AngioDynamics Inc's devices for various medical procedures.

    Revenue Streams

    AngioDynamics Inc generates revenue primarily through the sales of its medical devices. The company offers a wide range of products, including vascular access devices, ablation systems, and thrombolytic catheters. These products are sold to healthcare institutions and professionals at a competitive price, generating revenue for the company.

    Additionally, AngioDynamics Inc may generate revenue through licensing agreements, partnerships, and collaborations with other companies in the healthcare industry.


    By analyzing AngioDynamics Inc's Business Model Canvas, we can see how the company strategically operates in the healthcare industry. Through key partnerships, activities, resources, and a strong value proposition, AngioDynamics Inc delivers innovative medical devices to its customer segments, generating revenue and improving patient outcomes. Understanding the Business Model Canvas can provide valuable insights into a company's overall strategy and its position within the market.

    Which companies are the competitors of AngioDynamics Inc?

    Competitors of AngioDynamics Inc

    AngioDynamics Inc operates in the medical devices industry, specifically focusing on the development and manufacturing of minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology. In this highly competitive market, AngioDynamics faces several notable competitors.

    1. Becton, Dickinson and Company (BD)

    BD is a leading global medical technology company that operates in various segments, including medication management, diagnostics, and medical devices. With a diverse portfolio of products, BD competes with AngioDynamics in the vascular access and peripheral vascular disease market. BD's extensive range of medical devices and strong brand presence make it a formidable competitor for AngioDynamics.

    2. Medtronic plc

    Medtronic is a multinational medical technology company that offers a wide range of innovative medical devices and therapies. With a strong focus on vascular solutions, Medtronic competes directly with AngioDynamics in areas such as vascular access, peripheral vascular disease, and oncology. Medtronic's global presence and robust research and development capabilities make it a significant competitor in the market.

    3. Boston Scientific Corporation

    Boston Scientific is a leading medical device manufacturer that specializes in a variety of healthcare areas, including interventional cardiology, peripheral interventions, and oncology. With a comprehensive product portfolio and a focus on developing advanced technologies, Boston Scientific poses a competitive threat to AngioDynamics. Both companies strive to provide minimally invasive solutions for patients, making this rivalry intense.

    4. Cook Medical Inc

    Cook Medical is a family-owned medical device company that operates globally. They manufacture and distribute a broad range of products, including devices used in interventional radiology, peripheral vascular disease, and oncology. Cook Medical competes directly with AngioDynamics in the vascular access and peripheral vascular disease market segments. With its strong reputation and commitment to innovation, Cook Medical is a notable competitor for AngioDynamics.

    5. Terumo Corporation

    Terumo Corporation is a Japanese medical device company that focuses on three main business areas: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. In the vascular access and peripheral vascular disease market, Terumo competes with AngioDynamics. The company's diverse product portfolio and global presence make it a significant competitor in the industry.

    In conclusion, AngioDynamics faces stiff competition from established players like Becton, Dickinson and Company, Medtronic, Boston Scientific Corporation, Cook Medical Inc, and Terumo Corporation. These competitors offer a wide range of medical devices and therapies in areas that directly overlap with AngioDynamics' product offerings. To stay ahead, AngioDynamics must continue to differentiate itself through innovation, quality, and strategic partnerships.

    AngioDynamics Inc SWOT Analysis


    • Strong market position: AngioDynamics Inc has established itself as a leading player in the medical device industry, particularly in the field of minimally invasive medical treatments. The company's innovative and reliable products have gained a strong foothold in the market, enabling it to maintain a competitive advantage over its peers.

    • Diverse product portfolio: AngioDynamics Inc offers a wide range of products and solutions, including vascular access devices, dialysis catheters, and laser ablation systems. This diverse product portfolio allows the company to cater to various medical specialties and meet the unique needs of healthcare professionals and patients.

    • Robust research and development capabilities: The company has a strong focus on research and development, investing significant resources in developing new and improved products. This commitment to innovation has enabled AngioDynamics Inc to stay ahead of the curve and continuously introduce cutting-edge medical technologies to the market.


    • Dependence on a limited number of customers: Despite its strong market position, AngioDynamics Inc relies heavily on a few key customers for a significant portion of its revenue. This concentration of customer base poses a risk, as any loss or reduction in business from these customers could have a substantial negative impact on the company's financial performance.

    • Pricing pressures: The medical device industry is highly competitive, with price being a major factor influencing purchasing decisions. AngioDynamics Inc faces pricing pressures from both competitors and healthcare providers who are increasingly seeking cost-effective solutions. This could potentially impact the company's profit margins and overall financial performance.


    • Growing demand for minimally invasive procedures: There is a growing trend towards minimally invasive treatments due to their benefits such as shorter recovery times, reduced hospital stays, and lower healthcare costs. AngioDynamics Inc is well-positioned to capitalize on this opportunity by offering innovative and advanced minimally invasive medical devices that cater to the evolving needs of healthcare providers and patients.

    • Expansion into emerging markets: The company has the potential to expand its presence in emerging markets, where there is a rising demand for high-quality medical devices. By leveraging its strong brand reputation and product portfolio, AngioDynamics Inc can tap into these untapped markets and drive further growth.


    • Stringent regulatory environment: The medical device industry is subject to strict regulations and compliance requirements, which can pose challenges for companies like AngioDynamics Inc. Any changes in regulations or failure to comply with existing ones can result in delays in product approvals or recalls, impacting the company's ability to bring new products to market and potentially leading to financial and reputational damage.

    • Intense competition: The medical device industry is highly competitive, with numerous players vying for market share. AngioDynamics Inc faces competition from both established companies and new entrants, which could potentially erode its market position and put pressure on its revenue and profitability.

    In conclusion, AngioDynamics Inc has several strengths, including a strong market position, diverse product portfolio, and robust research and development capabilities. However, the company also faces weaknesses such as dependence on a limited number of customers and pricing pressures. Nevertheless, there are opportunities for growth, including the growing demand for minimally invasive procedures and expansion into emerging markets. However, the company must also be mindful of threats such as the stringent regulatory environment and intense competition in the industry.

    Key Takeaways

    • AngioDynamics Inc is owned by various institutional investors, with the largest shareholders being Vanguard Group and BlackRock.

    • The mission statement of AngioDynamics Inc is to provide innovative medical devices and solutions that enable healthcare professionals to improve patient outcomes.

    • AngioDynamics Inc generates revenue primarily through the sale of medical devices and products related to minimally invasive procedures.

    • The Business Model Canvas of AngioDynamics Inc focuses on key elements such as value proposition, customer segments, channels, customer relationships, revenue streams, key resources, key activities, key partnerships, and cost structure.

    • Some of the main competitors of AngioDynamics Inc include Medtronic, Boston Scientific, and Johnson & Johnson.

    • In terms of SWOT analysis, AngioDynamics Inc's strengths include a diverse product portfolio, strong distribution network, and focus on innovation. However, the company faces challenges such as intense competition, regulatory scrutiny, and dependence on third-party suppliers. Opportunities for AngioDynamics Inc include market expansion and strategic partnerships, while threats include changing healthcare policies and economic uncertainties.


    In conclusion, AngioDynamics Inc is a medical device company that specializes in minimally invasive medical treatments. The company is publicly traded and its ownership is distributed among various institutional and individual investors.

    The mission statement of AngioDynamics Inc is to provide innovative medical solutions to healthcare professionals and patients, improving patient outcomes and enhancing the quality of life.

    The company generates revenue through the sale of its medical devices and related products, which are used in a wide range of medical procedures. These products include vascular access devices, surgical instruments, and peripheral vascular devices, among others.

    The business model canvas of AngioDynamics Inc highlights key aspects of the company's operations, including its value proposition, customer segments, key activities, and revenue streams. The company focuses on creating value for its customers by offering high-quality, reliable, and cost-effective medical devices.

    Competitors of AngioDynamics Inc include other medical device companies such as Boston Scientific Corporation, Medtronic, and Johnson & Johnson. These companies also offer a range of medical devices and compete for market share in the healthcare industry.

    In terms of a SWOT analysis, AngioDynamics Inc has several strengths, including a strong product portfolio, a focus on innovation, and a global presence. However, the company also faces challenges such as intense competition, regulatory pressures, and potential market saturation. By leveraging its strengths and addressing its weaknesses, AngioDynamics Inc can continue to grow and maintain its position in the market.

    Overall, AngioDynamics Inc is a reputable company in the medical device industry, with a clear mission to provide innovative medical solutions. Through its business model and strategic approach, the company generates revenue and competes with other industry leaders. By understanding its competitors and conducting a thorough SWOT analysis, AngioDynamics Inc can navigate the challenges of the market and continue to thrive in the healthcare industry.


    How can I find a SWOT analysis on a company?

    There are several ways to find a SWOT analysis on a company:

    1. Company website: Check the investor relations or about us section of the company's official website. Some companies may have a SWOT analysis available in their annual reports, corporate presentations, or other public documents.

    2. Business databases: Many business databases, such as Bloomberg, Hoovers, or Factiva, provide SWOT analyses for various companies. These databases often require a subscription or access through a library or educational institution.

    3. Market research reports: Look for market research reports from reputable sources like MarketResearch.com, IBISWorld, or Statista. These reports often include SWOT analyses as part of their company profiles.

    4. Business news websites: Websites like Forbes, Business Insider, or CNBC may occasionally publish SWOT analyses of well-known companies. Use the search function on these websites and look for articles that specifically mention the company you are interested in.

    5. Online search: Conduct a search on search engines like Google using the company name plus "SWOT analysis." You may come across SWOT analyses conducted by industry experts, consulting firms, or academic institutions.

    6. Business journals and publications: Check academic journals or business publications like Harvard Business Review, The Wall Street Journal, or The Economist. They sometimes publish SWOT analyses or related articles that discuss the strengths, weaknesses, opportunities, and threats of a particular company.

    Remember that a SWOT analysis is often subjective and can vary depending on the source. It is recommended to gather information from multiple reliable sources to get a comprehensive understanding of a company's SWOT analysis.

    What is a SWOT analysis for a medical company?

    A SWOT analysis for a medical company involves evaluating its internal strengths and weaknesses, as well as external opportunities and threats. Here is an example:


    1. Highly skilled and experienced medical professionals.
    2. Strong reputation and brand recognition in the market.
    3. State-of-the-art medical facilities and equipment.
    4. Extensive network of partnerships with healthcare providers.
    5. Robust financial resources for research and development.


    1. Relatively higher costs of medical services compared to competitors.
    2. Limited geographical reach or presence in certain regions.
    3. Potential gaps in certain medical specialties or services.
    4. Inefficient administrative processes and bureaucratic structures.
    5. Lack of diversity in the leadership team.


    1. Increasing demand for advanced medical treatments and technologies.
    2. Growing aging population and prevalence of chronic diseases.
    3. Expansion into new markets or regions with underserved healthcare needs.
    4. Collaboration with pharmaceutical companies for clinical trials and drug development.
    5. Development of telemedicine and digital health solutions.


    1. Intense competition from other established medical providers.
    2. Regulatory changes and compliance requirements.
    3. Economic instability or healthcare policy reforms.
    4. Potential lawsuits or medical malpractice claims.
    5. Negative public perception due to medical errors or ethical controversies.

    Which companies have a SWOT analysis?

    Many companies have a SWOT analysis, as it is a commonly used tool for strategic planning and assessment. Some well-known companies that have publicly available SWOT analyses include:

    1. Apple Inc.
    2. Google (Alphabet Inc.)
    3. Amazon.com Inc.
    4. Microsoft Corporation
    5. Coca-Cola Company
    6. Walmart Inc.
    7. Facebook Inc.
    8. Tesla Inc.
    9. Nike Inc.
    10. McDonald's Corporation

    Please note that these are just a few examples, and there are numerous other companies that have conducted SWOT analyses.

    What are the four 4 parts of SWOT analysis?

    The four parts of SWOT analysis are:

    1. Strengths: These are the internal factors that give an organization a competitive advantage over others. Strengths can include unique resources, skills, or capabilities that differentiate the organization from its competitors.

    2. Weaknesses: These are the internal factors that hinder an organization's performance or put it at a disadvantage compared to its competitors. Weaknesses can include lack of resources, skills gaps, or ineffective processes that need improvement.

    3. Opportunities: These are external factors in the business environment that can be leveraged to create growth or positive outcomes for the organization. Opportunities can arise from market trends, technological advancements, or changes in customer preferences.

    4. Threats: These are external factors that pose challenges or risks to the organization's success. Threats can include competition, economic downturns, regulatory changes, or shifts in consumer behavior.

    Want to create a presentation now?

    • instantly

      Instantly Create A Deck

      Let PitchGrade do this for me

    • smile

      Hassle Free

      We will create your text and designs for you. Sit back and relax while we do the work.

    Explore More Content